A neurologist explains how insurance companies deny or delay Alzheimer's treatments, causing irreversible cognitive decline for patients.

Three state legislatures have moved forward with dementia-related legislation that includes mandating biomarker testing coverage by insurance plans, creating new memory care licensure and creating a ...

Publisher's note: This series was paid for by National Minority Quality Forum. The views expressed are the authors' own. Nearly seven million Americans currently live with Alzheimer's disease, a ...

High-dose vaccine tied to roughly 20% lower risk of Alzheimer's dementia ...

New research suggests that routine blood pressure checks may predict dementia risk years before symptoms, with one metric linked to a 76% higher risk in adults under 65.

Daily coffee consumption, if caffeinated, may be linked to lower risks of dementia in older adults. A study published in the ...

During the month of April, the Mayo Clinic Alzheimer’s Disease Research Center and Houston County Public Health will host a ...

Democratic and Republican attorneys general in nearly half of U.S. states are calling on Medicare to provide unrestricted coverage of antibody treatments for Alzheimer's disease, according to a letter ...

There are unique aspects and potential barriers to providing healthcare to people living with Alzheimer’s Disease and related dementias (ADRD), since they may be less capable than others of ...

Alzheimer's is not a disease you expect in your thirties. But after getting that devastating diagnosis, a Massachusetts woman ...

November’s Alzheimer’s Awareness Month is the best time to remind the world that we’re staring at a public health crisis with this disease. Especially in Florida. According to the Alzheimer’s ...

Ben Bahr leads the university’s Alzheimer’s Disease Research Lab, which is working to develop a low-cost treatment for the brain disorder.